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Abstract 
Background: Calotropis gigantea (Asclepiadaceae) (Niu jiao gua) has been used as a poultice in Chinese medicine for 
treating inflammatory skin diseases, e.g., neurodermatitis. This study aims to isolate the epidioxysterols from the flow‑
ers of C. gigantea, elucidate their structures and evaluate their possible inhibitory effects on the NF‑κB pathway.
Methods: The two epidioxysterols 9,11‑dehydroergosterol peroxide (1) and ergosterol peroxide (2) were isolated 
from the powdered flowers of C. gigantea by ultrasonic‑assisted extraction, followed by the purification of the crude 
extract by column chromatography (i.e., silica gel and MCI‑gel CHP 20P open columns). The chemical structures of 
these compounds were identified through a comparison of their HRMS, 1H and 13C NMR data with those in the lit‑
erature. The in vitro IKK‑β inhibitory activities of compounds 1 and 2 (1–100 µM) were evaluated using an IKK α and β 
Assay/Inhibitor Screening Kit, which is a single‑site, semi‑quantitative immunoassay. Berberine was used as a positive 
control. The IKK‑β inhibitory activities between compounds 1 and 2 were compared by a two‑tailed Student’s t test to 
summarize the structure activity relationship.
Results: Compounds 1 and 2 exhibited a dose‑dependent inhibitory activity towards IKK‑β in a similar manner to 
that of berberine. The IKK‑β inhibitory activities of these two epidioxysterols were significantly stronger (P = 0.001 for 
compound 1 and P = 0.028 for compound 2) than that of berberine at the concentration of 100 µM. Furthermore, at 
the same concentration the suppressive effect of compound 1 towards IKK‑β was greater than that of compound 2 
(P = 0.041), while their activities at 10 and 50 µM were comparable. The difference in the results at 100 µM therefore 
suggested that the double bond between C‑9 and C‑11 in compound 1 could be responsible for its higher inhibitory 
activity towards IKK‑β at this concentration.
Conclusions: 9,11‑dehydroergosterol peroxide (1) and ergosterol peroxide (2) were isolated from the flowers of  
C. gigantea and exhibited in vitro inhibitory activities towards IKK‑β.
© 2016 Parhira et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Calotropis gigantea (Asclepiadaceae; Niu jiao gua) 
(Fig. 1) has been used for centuries in Chinese medicine 
(CM) as a poultice for treating inflammatory skin dis-
eases such as neurodermatitis [1]. Several preparations 
containing C. gigantea, such as “Swarna bhasma”, are 
also used for the treatment of several other inflamma-
tory diseases, including asthma, rheumatoid arthritis and 
diabetes mellitus, in Ayurvedic medicine [2]. The ethyl 
acetate extract of the flowers of C. gigantea has been 
reported to exhibit antitumor activity against Ehrlich’s 
ascites carcinoma in vivo [3, 4]. A wide variety of bioac-
tive compounds have been isolated from different parts 
of C. gigantea, including flavonoids [5], cardenolides [6, 
7], sterols [8], pregnanone [9], triterpenes [10], non-pro-
tein amino acids [11] and lignan glycosides [12]. Among 
the various pharmacological activities reported for the 
compounds isolated from C. gigantea, their anticancer 
activities were the most significant of all [4–8].
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The two epidioxysterols 9,11-dehydroergosterol per-
oxide (1) and ergosterol peroxide (2), which are shown 
in Fig.  1, are normally found in medicinal mushrooms. 
These compounds have been reported to exhibit a wide 
variety of pharmacological properties, including anti-
inflammatory and anticancer activities [13–15]. It has 
been proposed that the anti-inflammatory activities of 
these compounds can be attributed to their inhibition of 
the nuclear factor kappa B (NF-κB) pathway [13]. NF-κB 
is involved in immune and inflammatory responses via 
the induction of pro-inflammatory genes. NF-κB is asso-
ciated with the regulatory protein IκBα in the cytoplasm. 
Upon activation, IκBα undergoes phosphorylation by 
the IκB kinase (IKK) complex, followed by ubiquitina-
tion-dependent degradation. This degradation process 
leads to the nuclear translocation of NF-κB to a spe-
cific DNA sequence, which results in the transcription 
of genes related to immune, inflammatory and tumo-
rigenic responses [16–18]. IKK-β, which is an essential 
functional subunit of the IKK complex, is the key kinase 
responsible for the phosphorylation of IκBα. The inhibi-
tion of IKK-β can therefore be used as an efficient strat-
egy to block NF-κB-mediated inflammatory responses. 
The discovery of new agents capable of inhibiting IKK-β, 
especially those from natural sources, could be useful for 
developing novel drugs for the treatment of inflamma-
tory diseases and cancer.
It has been reported that compounds 1 and 2 can sup-
press LPS-induced inflammatory responses through their 
inhibition of the NF-κB pathway, as well as inhibiting the 
growth of certain cancer cells, including HT29 (human 
colon adenocarcinoma cells), HL60 (human leukemia 
cells) and Hep 3B (human hepatocellular carcinoma 
cells) cells [13, 19, 20]. Moreover, compound 1 does not 
significantly inhibit the growth of WI38 cells (normal 
embryonic human fibroblasts) [19]. These studies there-
fore highlight the potential of these two promising epidi-
oxysterols for the development of anti-inflammatory and 
anticancer agents.
The results of previous reports pertaining to the inhibi-
tory effects of compounds 1 and 2 towards NF-κB tran-
scription with unknown molecular target [13–15] led us 
to investigate their in  vitro IKK-β inhibitory activities 
with the aim of identifying their target. This study aims 
to isolate these two epidioxysterols from the flowers of C. 
gigantea, elucidate their structures and investigate their 
inhibitory effects towards the IKK-β enzyme.
Methods
Chemicals and reagents
Chloroform, methanol, petroleum ether (40‒60  °C) and 
acetone (AR grade) were purchased from RCI Labscan 
Limited (Bangkok, Thailand). Deuterated chloroform 
(CDCl3) for NMR analysis was purchased from Cam-
bridge Isotope Laboratories, Inc. (Andover, MA, USA). 
Berberine was purchased from the National Institutes for 
Food and Drug Control of China (Beijing, China).
General experimental procedures
The 1H and 13C NMR spectra were recorded on a Bruker 
Ascend 600 NMR spectrometer (Bruker, Karlsruhe, 
Germany; 600 and 150  MHz for the 1H and 13C NMR, 
respectively). All of the samples were prepared in CD3Cl 
and the chemical shifts of the solvent were used as inter-
nal references. The chemical shifts (δ) have been given in 
ppm, and the coupling constants (J) have been presented 
Fig. 1 Flowers of Calotropis gigantea and chemical structures of compounds 1 and 2
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in Hz. High resolution mass spectrometry (HRMS) 
experiments were performed using an Agilent 6230 time-
of-flight (TOF) mass spectrometer (Agilent, Santa Clara, 
CA, USA) with an atmospheric pressure chemical ioni-
zation (APCI) source. Purifications by column chroma-
tography (CC) were performed over silica gel (40‒63 µm, 
Grace, Columbia, MD, USA) and MCI-gel CHP 20P 
(75‒150 µm, Mitsubishi Chemical Co. Ltd, Tokyo, Japan). 
Thin-layer chromatography (TLC) was conducted on 
pre-coated TLC Kieselgel 60 F254 plates (200  µm thick, 
Merck KGaA, Darmstadt, Germany). The TLC plates 
were visualized under ultraviolet (UV) light irradiation 
at a wavelength of 254 nm (Spectroline®, New York, NY, 
USA), as well as being sprayed with a 95  % EtOH solu-
tion containing 5 % sulfuric acid, followed by heating at 
110 °C.
Plant materials
Fresh C. gigantea flowers were purchased from a local 
market in Nakornprathom, Thailand during the months 
of October and November, 2010. The flowers were then 
air-dried at room temperature before being powdered in 
a blender. Each herbarium specimen was authenticated 
by comparison of morphological characteristics with an 
authenticated herbarium specimen of C. gigantea (No. 
MUST-CG201011), which was previously authenticated 
elsewhere [7, 12]. A voucher specimen of this plant (No. 
MUST–CG201012) was deposited at the State Key Labo-
ratory of Quality Research in Chinese Medicine, Macau 
University of Science and Technology, China.
Extraction and isolation
The powdered air-dried flowers of C. gigantea (2.0  kg) 
were extracted with MeOH three times (1  h for each 
extraction) under ultrasonic using a Crest ultrasonic 
cleaner (Model 2800 HT, Che Scientific Co., Hong Kong) 
at ambient temperature. This process afforded a yellow 
residue (329.0  g), which was purified by CC over silica 
gel (CH3Cl3–MeOH–H2O, 10:0:0 to 6:4:1—v/v) to give 4 
fractions (Fractions A to D). Fraction C (5.8 g) was sub-
jected to MCI CC (MeOH–H2O, 50:50 to 100:0—v/v) to 
obtain 9 fractions (Fractions C-1 to C-9). Fraction C-7 
(1.0  g) was purified by CC over silica gel (PE-acetone, 
10:0 to 5:5—v/v) to afford 11 fractions (Fractions C-7–1 
to C-7–11). Fraction C-7–6 (267.0 mg) was finally puri-
fied by MCI CC (MeOH–H2O, 80:20 to 100:0) to yield 
compound 1 (12.0  mg) and compound 2 (17.0  mg) 
(Fig. 2).
Kinase assay
An IKK α and β Assay/Inhibitor Screening Kit (CycLex, 
Nagano, Japan) and the IKK-β enzyme (2 units/200  µL, 
CycLex, Japan) were used to screen the IKK-β inhibitory 
activities of compounds 1 and 2, as well as that of the 
reported IKK-β inhibitor berberine [16], at concentra-
tions in the range of 1–100 µM according to the manu-
facturer’s protocol [21]. Briefly, the tested compounds 
were dissolved in dimethyl sulfoxide (DMSO) to obtain 
10 mM stock solutions. The stock solutions were diluted 
at least ten-fold with kinase buffer to afford the sample 
solutions. Each sample solution (10 µL) or a blank con-
trol (10  µL of 10  % DMSO in kinase buffer) was added 
into a well pre-coated with a substrate corresponding to 
recombinant IκBα on ice. The IKK-β enzyme (10 mUnits/
µL) was diluted ten-fold with kinase buffer, and 10  µL 
of the diluted enzyme solution was added to each well. 
Each well was then treated with 80  µL of a freshly pre-
pared adenosine triphosphate (ATP) solution (62.5  µM 
in kinase buffer). The total volume of each reaction was 
100  µL containing the desired concentrations of 1, 10, 
50 and 100  µM of the test compounds. A solution of 
1  % DMSO in kinase buffer was used as a solvent con-
trol. The wells were subsequently incubated at 30 °C with 
gentle shaking at 90  rpm for 30 min. The reaction mix-
tures in each well were discarded, and then washed five 
times with 100 µL of 10X washing buffer containing 2 % 
Tween®-20. An anti-phospho-IκBα-S32 monoclonal anti-
body (AS-2E8, 100 µL) was added to the wells, and the 
resulting mixtures were incubated at 25  °C with gentle 
shaking (90  rpm) for 30  min. After discarding the reac-
tion mixtures and washing the wells five times with 10X 
washing buffer containing 2 % Tween®-20, each well was 
treated with 100  µL of a horseradish peroxidase (HRP) 
conjugated anti-mouse IgG solution, before being incu-
bated under the same condition as those described the 
previous step for 30  min. All of the reaction mixtures 
were subsequently discarded and the well washed five 
times with 10X washing buffer containing 2 % Tween®-
20 before being treated with tetramethylbenzidine (TMB, 
100 µL) and incubated at 25 °C with shaking at 90 rpm for 
15 min. The reactions were terminated by the addition of 
a 0.5 N solution of sulfuric acid (100 µL), followed by the 
agitation of the resulting mixtures on a shaker for 5 min 
at room temperature. Finally, the absorbance of the sam-
ple solutions was measured at a wavelength of 450  nm 
using a multimode reader (Infinite M200 PRO, Tecan, 
Männedorf, Switzerland). All of the samples were assayed 
in triplicate. The solvent control was regarded as 100 % 
phosphorylation of IκBα by the IKK-β enzyme [21].
Statistical analysis
The IKK-β activities of the compound-treated vials were 
normalized based on the activity of the solvent control, 
which was regarded as 100 % of the IKK-β activity. These 
values were then expressed as the mean ± standard 
deviation (SD). Differences between the results of each 
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compound and berberine at all tested concentrations 
were performed by a two-tailed Student’s t test and sub-
sequent Bonferroni correction of P values. In addition, 
IKK-β inhibitory activities between compounds 1 and 
2 at all tested concentrations were also compared using 
a two-tailed Student’s t test in order to summarize the 
structure activity relationship. Differences were consid-
ered statistically significant for P  <  0.05. Dose-depend-
ency was determined visually by observing the trends of 
the data.
Results
Isolation and structural elucidation of compounds 1 and 2
The methanolic extract of the air dried flowers of C. 
gigantea was subjected to a series of normal and reverse 
phase chromatographic purification process to obtain 
compounds 1 and 2 (Fig.  1). The molecular formula of 
compound 1 was determined to be C28H42O3 by HRMS 
in the positive ionization mode, which gave a molecular 
ion with an m/z value of 427.3186 for [M+H]+ (calcd for 
[M+H]+ 427.3207, with a measurement error of 4.9 ppm) 
(Additional file 1). HRMS analysis also revealed fragment 
ions with m/z values of 409.3087, 393.3134 and 375.3031, 
corresponding to [M−H2O+H]+, [M−H2O2+H]+ and 
[M−H2O2−H2O+H]+, respectively, which suggested the 
presence of hydroxyl and peroxy groups in this molecule 
[19, 22].
The 1H NMR spectrum of compound 1 (Additional 
file  2) contained signals consistent with the presence of 
six methyl groups [δH 1.09, s, H-19; δH 0.73, s, H-18; δH 
1.00, d (J = 6.6 Hz), H-21; δH 0.91, d (J = 7.2 Hz), H-28; 
δH 0.83, d (J = 6.6 Hz), H-26 and δH 0.82, d (J = 7.2 Hz), 
H-27] and five olefinic protons [δH 5.42, dd (J  =  6.0, 
1.8  Hz), H-11; δH 6.28, d (J  =  8.4  Hz), H-6; δH 6.59, d 
(J = 8.4 Hz), H-7; δH 5.16, dd (J = 15.0, 8.4 Hz), H-22 and 
δH 5.24, dd (J = 15.0, 7.8 Hz), H-23]. The coupling con-
stant between H-6 and H-7 was around 8.4  Hz, which 
suggested that these two protons were coupled with each 
Fig. 2 Schematic illustration of the isolation and purification of compounds 1 and 2
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other in a cis-orientation, whereas the coupling pattern 
between H-22 and H-23 was consistent with these pro-
tons sitting in a trans-orientation based on their large 
coupling constant (15.0 Hz).
The 13C NMR spectrum of compound 1 (Additional 
file  3) contained 28 carbon signals (Table  1). Six of the 
carbon signals in the down field region of the spectrum 
were consistent with the presence of three double bonds 
(δC 135.4, C-6; δC 130.7, C-7; δC142.5, C-9; δC 119.7, 
C-11; δC 135.1, C-22 and δC 132.4, C-23). Three oxygen-
ated carbons (δC 82.7, C-5; δC 78.4, C-8 and δC 66.3, C-3) 
were also observed in the 13C NMR spectrum. The 19 
remaining carbon signals were consistent with the pres-
ence of quaternary carbons and aliphatic carbons (e.g., 
methine, methylene and methyl carbons). Taken together 
with NMR data (Table  1) from the literature [19, 23], 
these data indicated that compound 1 was 9,11-dehydro-
ergosterol peroxide.
The HRMS analysis of compound 2 in the posi-
tive ion mode (Additional file  4) gave a molecular ion 
with an m/z value of 429.3346 for [M+H]+ (calcd 
for [M+H]+=  429.3363 with measurement error of 
4.0  ppm). This result indicated that the mass of com-
pound 2 was two mass units greater than that of com-
pound 1, suggesting that the molecular formula of 
compound 2 was C28H44O3. The fragmentation pattern 
in the mass spectrum of compound 2 was very similar 
to that of compound 1. The detection of fragment ions 
with m/z values of 411.3239 [M−H2O+H]+, 395.3292 
[M−H2O2+H]+ and 377.3191 [M−H2O2−H2O+H]+ 
indicated that compound 2 contained hydroxyl and per-
oxy groups [19].
The 1H NMR spectrum of compound 2 (Additional 
file 5) showed six methyl groups [δH 0.94, d (J = 6.6 Hz), 
H-21; δH 0.86, d (J = 6.6 Hz), H-28; δH 0.83, brs, H-19;δH 
0.78, d (J = 6.6 Hz), H-27; δH 0.76, d (J = 6.6 Hz), H-26 
and δH 0.76, brs, H-18] and four olefinic protons [δH 6.45, 
d (J = 8.4 Hz), H-7; δH 6.19, d (J = 8.4 Hz), H-6; δH 5.17, 
dd (J  =  15.0, 7.8  Hz), H-23 and δH 5.09, dd (J  =  15.0, 
8.4 Hz), H-22].
The 13C NMR spectrum of compound 2 (Additional 
file  6) contained signals consistent with the presence of 
three oxygenated carbons (δC 82.3, C-5; δC 79.6, C-8 and 
δC 66.1, C-3) and two C=C double bonds in the down 
field region (δC 135.2, C-6; δC 130.6, C-7; δC 135.5, C-22 
and δC 132.3, C-23), which were similar to those observed 
for compound 1, except for the absence of one C=C dou-
ble bond. Notably, these spectroscopic data were con-
sistent with those reported in the literature for a known 
compound [19, 23, 24]. Compound 2 was therefore char-
acterized as ergosterol peroxide.
IKK‑β inhibitory activity of compounds 1 and 2
IKK-β, which is a key subunit of IKK [17], is involved in 
the phosphorylation of IκBα as part of the signaling path-
way responsible for the transcription of NF-κB [25]. The 
IKK-mediated phosphorylation of the Ser32 and Ser36 
residues of cytoplasmic IκBα leads to the poly-ubiquit-
ination and subsequent proteasomal degradation of IκBα, 
which results in the release of NF-κB and its subsequent 
translocation to the nucleus [17, 18].
Compounds 1 and 2 have been reported to exhibit 
anti-cancer and anti-inflammatory effects through their 
ability to inhibit the NF-κB signaling pathway [13–15]. 
The in vitro inhibitory effects of these two epidioxyster-
ols towards IKK-β were evaluated in the current study 
using a CycLex IKK-β Assay/Inhibitor Screening Kit, 
which is a single-site, semi-quantitative immunoassay. 
Briefly, the IKK-β enzyme and the recombinant IκBα sub-
strate (pre-coated on the bottom of the wells) were incu-
bated in the presence of ATP and various concentrations 
Table 1 1H and  13C NMR data of  compounds 1 and  2 
in CDCl3
Position 1 2
δC δH (J in Hz) δC δH (J in Hz)
1 32.6 34.7
2 30.6 29.6
3 66.3 4.01 (m) 66.1 3.86 (m)
4 36.0 36.7
5 82.7 82.3
6 135.4 6.28 (d, 8.4) 135.2 6.19 (d, 8.4)











18 13.0 0.73 (s) 12.8 0.76 (brs)
19 25.6 1.09 (s) 18.1 0.83 (brs)
20 39.9 39.7
21 20.7 1.00 (d, 6.6) 20.8 0.94 (d, 6.6)
22 135.1 5.16 (dd, 15.0, 8.4) 135.5 5.09 (dd, 15.0, 8.4)
23 132.4 5.24 (dd, 15.0, 7.8) 132.3 5.17 (dd, 15.0, 7.8)
24 42.8 42.7
25 33.1 33.0
26 19.9 0.83 (d, 6.6) 19.6 0.76 (d, 6.6)
27 19.6 0.82 (d, 7.2) 19.9 0.78 (d, 6.6)
28 17.6 0.91 (d, 7.2) 17.5 0.86 (d, 6.6)
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of compounds 1 and 2 in the wells of a 96-well plate at 
30 °C for 30 min. The phosphorylated IκBα substrate was 
detected using an AS-2E8 specific antibody, followed 
by a HRP-conjugated secondary antibody with subse-
quent color development using a TMB substrate. A dilute 
H2SO4 solution was used to stop the color development 
and the absorbance was read at 450 nm. The absorbance 
was directly related to the level of IKK-β activity.
As shown in Fig.  3 and Table  2, compounds 1 and 2 
exhibited dose-dependent inhibitory activity towards 
IKK-β in a similar manner to the control compound 
berberine. At concentrations in the range of 1–50  μM, 
the percentage inhibition values of compounds 1 and 
2 towards IKK-β were in the ranges of 9.6–24.4  % and 
15.8–24.0 %, respectively. In general, the inhibitory activ-
ities of the two epidioxysterols towards IKK-β were simi-
lar to that (13.0–17.4 %) of berberine. Interestingly, at a 
concentration of 100 μM, the inhibitory activities of com-
pounds 1 and 2 towards IKK-β were 1.7 fold (P = 0.001) 
and 1.4 fold (P = 0.028), respectively, greater than that of 
berberine. Furthermore, compound 1 exhibited greater 
inhibitory activity towards IKK-β than compound 2 
(P  =  0.041) at the same concentration. However, the 
activities of these two compounds were much similar at 
the lower concentrations of 10 and 50 μM. These results 
therefore indicated that the C=C double bond between 
C-9 and C-11 in 9,11-dehydroergosterol peroxide could 
responsible for the enhanced activity of this compound 
towards IKK-β at the higher dose.
Discussion
A kinase assay was used to examine the inhibitory activi-
ties of compounds 1 and 2 towards IKK-β and the NF-κB 
pathway. Berberine (10  µM) effectively attenuated the 
activity of IKK-β using an immunocomplex kinase assay 
method [16]. In contrast, the same concentration of ber-
berine only inhibited the activity of IKK-β by 14 % in the 
current study, which suggested that the assay method 
used in the current study was not as sensitive as the 
immunocomplex kinase assay. Furthermore, compounds 
1 and 2 exhibited greater inhibitory activities towards 
IKK-β than that of berberine at a high concentration of 
100 μM. However, it remains unclear whether the inhibi-
tory activity of these compounds was due to them bind-
ing directly to IKK-β in a similar manner to berberine. 
Further study will therefore be required to elucidate the 
mechanism of action of these compounds.
Our results revealed that compound 1 exhibited 
greater inhibitory activity towards IKK-β than com-
pound 2 at 100 µM. Furthermore, the IC50 values of com-
pounds 1 and 2 towards Hep 3B cancer cells were 39.2 
and 45.3  µM, respectively [20]. The parallels between 
the IKK-β inhibitory activities and cytotoxicities of these 
compounds towards cancer cells indicated the existence 
of a structure activity relationship involving the double 
bond between C-9 and C-11. This double bond appeared 
to contribute to the IKK-β inhibitory activity and cyto-
toxicity of 9,11-dehydroergosterol peroxide (1) at the 
higher concentration of 100  µM. This result indicated 
Fig. 3 Relative IKK‑β activities of compounds 1 and 2. The results represent the mean ±SD from three independent experiments. The P values are 
shown as indicated
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that more planar ergosterol peroxide derivatives could 
show more potent inhibitory effects towards IKK-β. 
This structure activity relationship could therefore guide 
the future design and synthesis of more planar dehy-
drated derivatives based on these two epidioxysterols as 
stronger IKK-β inhibitors. Although the inhibitory activi-
ties of compounds 1 and 2 towards IKK-β were limited to 
the in vitro kinase assay in the present study, cell-based 
bioassays could be performed to determine whether the 
IKK-β enzyme is the direct target of these two epidioxys-
terols in the NF-κB pathway.
This study provided the first example of the isolation of 
compounds 1 and 2 from a plant in the Asclepiadaceae 
family. Moreover, this is also the first demonstration the 
in vitro IKK-β inhibitory activities of ergosterol peroxide 
and its derivative.
Conclusion
Two epidioxysterols, 9,11-dehydroergosterol peroxide (1) 
and ergosterol peroxide (2), were isolated from the flow-
ers of C. gigantea and exhibited in vitro IKK-β inhibitory 
activities at concentrations in the range of 10–100 µM.
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